NASDAQ:HEXO - HEXO Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HEXO Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.79 -0.30 (-27.52 %) (As of 03/30/2020 04:00 PM ET) Add Compare Today's Range$0.77Now: $0.79▼$0.9950-Day Range$0.36MA: $1.06▼$1.5252-Week Range$0.35Now: $0.79▼$8.40Volume7.87 million shsAverage Volume5.49 million shsMarket Capitalization$224.45 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email HEXO Corp., through its subsidiary, HEXO Operations Inc., produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names. The company serves medical and adult-use markets. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. is headquartered in Gatineau, Canada.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HEXO Previous Symbol CUSIPN/A CIKN/A Webhttp://hexo.com/ Phone844-406-1852Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares284,116,000Market Cap$224.45 million Next Earnings Date4/1/2020 (Estimated) OptionableOptionable Receive HEXO News and Ratings via Email Sign-up to receive the latest news and ratings for HEXO and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:HEXO Rates by TradingView HEXO (NASDAQ:HEXO) Frequently Asked Questions How has HEXO's stock been impacted by COVID-19 (Coronavirus)? HEXO's stock was trading at $0.9376 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HEXO stock has decreased by 15.7% and is now trading at $0.79. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of HEXO? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HEXO in the last year. There are currently 9 sell ratings, 6 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for HEXO. When is HEXO's next earnings date? HEXO is scheduled to release its next quarterly earnings announcement on Wednesday, April 1st 2020. View our earnings forecast for HEXO. What price target have analysts set for HEXO? 17 brokers have issued 12-month price targets for HEXO's shares. Their forecasts range from $1.00 to $7.17. On average, they anticipate HEXO's share price to reach $2.46 in the next year. This suggests a possible upside of 211.3% from the stock's current price. View analysts' price targets for HEXO. Has HEXO been receiving favorable news coverage? News articles about HEXO stock have been trending negative recently, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. HEXO earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutHEXO. Who are some of HEXO's key competitors? Some companies that are related to HEXO include Knight Therapeutics (GUD), HLS Therapeutics (HLS), Ecofibre (EOF), OrganiGram (OGI), ICC Labs (ICC), Next Science (NXS), Benchmark (BMK), Amryt Pharma (AMYT), Probiotec (PBP), CannTrust (TRST), Auscann Group (AC8), ESSA Pharma (EPI), Supreme Cannabis (FIRE), Shield Therapeutics (STX) and WeedMD (WMD). What other stocks do shareholders of HEXO own? Based on aggregate information from My MarketBeat watchlists, some companies that other HEXO investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Aphria (APHA), OrganiGram (OGI), Charlotte's Web (CWBHF), Aurora Cannabis (ACB), NVIDIA (NVDA), Tilray (TLRY) and KushCo (KSHB). Who are HEXO's key executives? HEXO's management team includes the following people: Mr. Sebastien G. St-Louis, Co-Founder, Pres, CEO & Director (Age 35)Mr. Adam Miron, Co-founder, Chief Brand Officer & Director (Age 35)Mr. Ed Chaplin, CFO & Corp. Sec. (Age 49)Mr. James McMillan, VP of Bus. Devel. (Age 51)Dr. Terence Lake DVM, Vice-Pres of Corp. & Social Responsibility What is HEXO's stock symbol? HEXO trades on the NASDAQ under the ticker symbol "HEXO." Who are HEXO's major shareholders? HEXO's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (0.50%), TD Asset Management Inc. (0.23%), Public Sector Pension Investment Board (0.21%), Swiss National Bank (0.16%), AdvisorShares Investments LLC (0.10%) and Bank of America Corp DE (0.10%). Which major investors are selling HEXO stock? HEXO stock was sold by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Ladenburg Thalmann Financial Services Inc., Public Sector Pension Investment Board, and TD Asset Management Inc.. Which major investors are buying HEXO stock? HEXO stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, AdvisorShares Investments LLC, FNY Investment Advisers LLC, Jane Street Group LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Goldman Sachs Group Inc., Cambria Investment Management L.P., and Cubist Systematic Strategies LLC. How do I buy shares of HEXO? Shares of HEXO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is HEXO's stock price today? One share of HEXO stock can currently be purchased for approximately $0.79. How big of a company is HEXO? HEXO has a market capitalization of $224.45 million. View additional information about HEXO. What is HEXO's official website? The official website for HEXO is http://hexo.com/. How can I contact HEXO? The company can be reached via phone at 844-406-1852. MarketBeat Community Rating for HEXO (NASDAQ HEXO)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 107 (Vote Outperform)Underperform Votes: 109 (Vote Underperform)Total Votes: 216MarketBeat's community ratings are surveys of what our community members think about HEXO and other stocks. Vote "Outperform" if you believe HEXO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HEXO will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/30/2020 by MarketBeat.com StaffFeatured Article: What is a Swap?
